Top News

Merck and Moderna logos displayed on a white background

RESEARCH

16 Jan 2026

mRNA Developers Regroup After Trial Setbacks

After late-stage failures, mRNA leaders narrow pipelines, double down on vaccines and cancer, and adopt tougher capital discipline

mRNA vaccine vial on medical documents with pills, syringe, and stethoscope

MARKET TRENDS

5 Feb 2026

mRNA Deals Push the Industry Beyond Vaccines

Biotech executives mark a major corporate milestone during a Nasdaq ceremony

PARTNERSHIPS

20 Jan 2026

GSK’s $2.2B Bet Signals a New Phase in Allergy Drug Races

Latest News

Sahin and Türeci Are Back at the Drawing Board

PARTNERSHIPS

7 Apr 2026

BioNTech co-founders will leave by year-end to launch a new next-gen mRNA company, with BioNTech taking a minority stake

PARTNERSHIPS

31 Mar 2026

RNA Meets Cell Therapy, and Texas Is Holding the Handshake

Cellipont and Soter Bio launch an integrated US platform linking GMP RNA production to cell therapy manufacturing

Gloved hand holding lab sample beside microscope equipment

REGULATORY

26 Mar 2026

No Trial? No Problem. FDA Rewrites the RNA Rules

FDA's Plausible Mechanism Framework opens a structured US approval route for RNA-based therapies targeting ultra-rare genetic diseases

Scientists working with laboratory instruments in biotech lab

INVESTMENT

23 Mar 2026

New Funding Backs Precision in mRNA Medicine

BreezeBio raises $60M to push precision mRNA delivery into the clinic, targeting diabetes and cancer with its NanoGalaxy platform

PARTNERSHIPS

17 Mar 2026

Fatty Bubbles and the $2.25 Billion Peace

Moderna settles landmark LNP patent dispute for up to $2.25B, securing a royalty-free delivery license for its infectious disease vaccine ...

Syringe being filled with vaccine dose in laboratory setting

REGULATORY

12 Mar 2026

Moderna's Flu Vaccine Clears a Regulatory Hurdle

A swift FDA reversal puts Moderna's mRNA flu shot back on track and sharpens the regulatory playbook for RNA developers

UChicago Medicine Comprehensive Cancer Center wall signage

INNOVATION

6 Mar 2026

Beta Cells Get a New Line of Defense

UChicago scientists use LNP-mRNA to protect insulin-producing cells from immune attack in type 1 diabetes

1 2 3...

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.